Search Results

Slosky Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the She received a Ph.D. in Medical Pharmacology from The University of Arizona in 2015 and completed a postdoctoral Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab research awards, including the William James Psychology Award, the Hank Yamamura Endowed Fellowship in Pharmacology She is currently a faculty trainer for the University of Minnesota's MS and Ph.D. programs in Pharmacology

graduate research on the regulation of axonal transport by tricyclic antidepressants (M.Sc.) and molecular pharmacology of opioid receptors (Ph.D.) in the Department of Pharmacology at the Université de Montréal under the The Tiberi Lab pursues the study of the molecular, structural, pharmacological and signaling features

Philip Seeman in the Department of Pharmacology at the University of Toronto. His training has provided a strong foundation and appreciation for the applications of pharmacology, Professor Sunahara started his independent research career in the Department of Pharmacology at the University In 2015 Professor Sunahara moved his laboratory to the Department of Pharmacology at the University of The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G

Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

Learn from pioneers shaping biased signaling, assay design, and pharmacology—skills you won't find it Terry Kenakin Terry's Corner Author of 'A Pharmacology Primer', the definitive GPCR reference used by Pioneer in quantitative pharmacology methods. Dr. Yamina Berchiche Dr. Also super-valuable for those of us learning how to teach pharmacology Anonymous Dr. A deep-dive training session led by top GPCR scientists, covering pharmacology, signaling, assays, and

Adriano received his Bachelor of Science degree in Pharmacology in 1991 from the University of Toronto his graduate studies at the University of Toronto where he earned his MSc (1994) and Ph.D. (1998) in Pharmacology In 2004 Adriano joined the faculty of the Department of Pharmacology at Loyola University Chicago.

Summary made with AI About Dmitry Veprintsev Dmitry is Professor of Molecular and Cellular Pharmacology Receptors (COMPARE), University of Nottingham, where he provides leadership in structural and biophysical pharmacology at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing his attention to structural pharmacology 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision pharmacology

postdoctoral fellow at the University of Michigan, joins the conversation as a rising voice in GPCR pharmacology GPCRs and the Opioid Crisis: A New Pharmacological Frontier Now at the University of Michigan, Ben focuses Scientific Rigor: The Value of ‘Old School’ Pharmacology Despite the availability of modern tools, Ben Using site-directed mutagenesis and pharmacological synergy assays , his team aims to understand how This project involves molecular pharmacology in cell models to determine binding sites and mechanisms

How GPCR pharmacology connects molecular insights to real-world interventions. how fentanyl and xylazine shut down breathing through different mechanisms—work that blends receptor pharmacology now and see how one scientist is turning molecules into a mission, bridging the gap between receptor pharmacology GPCR ecosystem , GPCR training program , GPCR podcast , opioid pharmacology , xylazine research , mu opioid receptor , pharmacogenomics , fentanyl epidemic , preclinical pharmacology Enjoying the Dr.

Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine. studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge of GPCRs pharmacology discovery and adopt data science methodology to tackle relevant scientific questions on the systems pharmacology

Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched at the Institute of Pharmacology He received a Ph.D. in pharmacology in 1992 from the Russian Academy of Medical Sciences and an M.D. Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology

Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Juergen Wess - Postdoc and Group leader in Aventis, now Sanofi, Frankfurt, Germany - Head of in vitro Pharmacology

Learn anytime, anywhere Access on-demand from any device Join Premium Today Explore the Masterclass Pharmacology Foundations Build the essential lens every scientist needs to see pharmacology clearly, from core principles Agonists, Antagonists & Core Mechanisms Master the classic players in GPCR pharmacology and learn how The classes are designed for researchers, students, and professionals in biology, pharmacology, and biochemistry Masterclasses cover a variety of track including but not limited to p harmacology foundations, agonists

Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging

Soon About Louis Gendron "Dr Louis Gendron, PhD is tenured Professor and Chair of the Department of Pharmacology-Physiology He has 20+ years of experience in in vitro and in vivo GPCR pharmacology and has published seminal papers

Caron is also past Associate Editor at JCI and served as the inaugural Associate Editor at ACS-Pharmacology Lauren Slosky "Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member She received a Ph.D. in Medical Pharmacology from The University of Arizona in 2015 and completed a postdoctoral Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab She is currently a faculty trainer for the University of Minnesota's MS and Ph.D. programs in Pharmacology

Debbie Hay is presently a professor at the Department of Pharmacology and Toxicology at the University Debbie obtained a Ph.D. in Molecular Pharmacology from Imperial College London in the UK.

accelerate your pipeline Book My Consultation Critical Bottlenecks in Your GPCR Pipeline ❌ Overwhelming pharmacology Actionable Scientific Validation: Ensure target companies execute the right GPCR pharmacology experiments Biology-First, Data-Driven Solutions Every recommendation is rooted in GPCR biology, pharmacology experience With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly In 2014, she was appointed Vice-Chair of the Department of Pharmacology. The long-term goal of Dr.

GPCR Podcast << Back to podcast list GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin 1 Starting at DuPont, then BMS, Novartis, and eventually founding in vitro pharmacology departments, Sokhom Falling in Love with GPCRs GPCR pharmacology captured his scientific curiosity. Sokhom recalls how binding assays at BMS introduced him to the depth and complexity of receptor pharmacology He blends classical receptor pharmacology with biosensor technology, always adapting to new tools and

This kind of predictive modeling challenges the traditional role of computation in pharmacology, where This episode is essential listening for anyone thinking seriously about translational pharmacology and

John Streicher from the department of pharmacology at the University of Arizona. John Streicher on the web University of Arizona Department of Pharmacology Google Scholar Pubmed LinkedIn

Breakthroughs this week: Potentiation of GPCR signaling by ATP and sugar monophosphates; Pharmacology 2025; Nxera Pharma 5 days ago Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Recognizing, predicting, and leveraging these interactions is the essence of enzyme inhibition pharmacology—the

Breakthroughs this week: Potentiation of GPCR signaling by ATP and sugar monophosphates; Pharmacology 2025; Nxera Pharma 5 days ago Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Recognizing, predicting, and leveraging these interactions is the essence of enzyme inhibition pharmacology—the

Breakthroughs this week: Potentiation of GPCR signaling by ATP and sugar monophosphates; Pharmacology 2025; Nxera Pharma 5 days ago Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Recognizing, predicting, and leveraging these interactions is the essence of enzyme inhibition pharmacology—the

bioSens-All: A Multiparametric BRET-Based Platform for Comprehensive Profiling of adhesion GPCR Signaling and Pharmacology-Enabling dissociation across different species, we plan to adapt this technology for high-throughput screening of pharmacological Richard Leduc (2) (1)Domain Therapeutics North America Inc, Montréal, Québec, Canada (2) Department of Pharmacology-Physiology Department of Pharmacology-Physiology, Université de Sherbrooke, Sherbrooke, Quebec, Canada 2. Our research aims to leverage this knowledge to identify novel pharmacological targets and contribute

moving to Nashville, TN for graduate work at Vanderbilt University where he joined the Department of Pharmacology Brian is involved in organizing the GRC/GRS Molecular Pharmacology meeting, which has been postponed

Alexander has a big interest in the integration of large biomedical data in genomics, structural biology, pharmacology During his Ph.D. with David Gloriam at the Department of Drug Design and Pharmacology in Copenhagen,

training at the University of New South Wales (UNSW) Sydney, Australia in 2016 with first class Honours in Pharmacology This project aims to characterise the molecular pharmacology of GPR146 and to validate the proposed ligands

Breakthroughs this week: Potentiation of GPCR signaling by ATP and sugar monophosphates; Pharmacology 2025; Nxera Pharma 5 days ago Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Recognizing, predicting, and leveraging these interactions is the essence of enzyme inhibition pharmacology—the